University of Minnesota
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Minnesota sits in the top decile of US sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count).
University of Minnesota: 966 sponsored US clinical trials, 180 recruiting.
University of Minnesota sponsors 966 registered US clinical trials on ClinicalTrials.gov, 180 of them currently recruiting, and 671 completed. 71 of these trials are in Phase 3-4 (later-stage) and 206 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 14 trials.
Top-decile sponsor footprint
University of Minnesota ranks in the top decile of sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
671 of 731 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
966 total, page 4 of 20
Brain Connectivity Patterns in Chronic Temporomandibular Joint Disorders
NCT05068908
The Cardiovascular Impact of Hot Flushes
NCT05251324
Visual Remapping to Aid Reading With Field Loss
NCT03848663
Geniculate Artery Embolization for Osteoarthritis
NCT04456569
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
NCT05117255
PCS in Severe Treatment Resistant Depression
NCT04124341
Improving Spinal Cord Stimulation With ECAPS
NCT04938245
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
NCT04910269
Neuromodulation and Cognitive Training for Substance Use Disorders
NCT04426214
Stimulation of the Larynx to Treat Unexplained Chronic Cough
NCT05273190
Poke and a Placebo
NCT04497220
Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis
NCT03587831
Multiple Objective Particle Swarm Optimization Postural Instability Gait Disorder
NCT05893186
Neuroplasticity in Parkinson's Disease
NCT05286736
Total Contact Soft Cast in Diabetic Foot Ulcers
NCT04210089
Treatment of ARDS With Instilled T3
NCT04115514
Feasibility of Identifying Brain Mechanisms of Qigong and Behavioral Outcomes After Qigong Practice in People With Chronic Low Back Pain
NCT04164225
Bupropion for the Prevention of Postpartum Smoking Relapse
NCT04098874
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
NCT04439370
Algorithms for Programming DBS Systems for ET
NCT03984643
Neuromodulation and Cognitive Training in Opioid Use Disorder
NCT03773523
PV Loop & Coarctation Study
NCT05362721
Post-contracture Release Radiation for Dupuytren's Disease
NCT04122313
Epidural Stimulation After Neurologic Damage
NCT03026816
Effects of Pallidal Deep Brain Stimulation Location on Motor Impairment in Parkinson's Disease
NCT05557864
Oxidative Stress and Inflammatory Biomarkers in Gaucher Disease
NCT02437396
Imaging Biomarkers in ALS
NCT02567136
A Natural History Study of the Gangliosidoses
NCT00668187
Natural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease Study
NCT01581424
University of Minnesota Transplant Registry
NCT01062581
Autonomous Digital CBT Intervention for Opioid Use Disorder in Individuals With Co-Occurring Internalizing Disorders
NCT06545071
Assessment of Customized Bimodal Stimulation for Tinnitus
NCT07092033
MRI of the TMJ in Patients With DJD
NCT07008690
Developing, Implementing and Evaluating Effective Community-facility Interactions to Improve Blood Availability and Transfusion in Three Distinct County Settings in Kenya
NCT06142825
Using a Mentoring Afterschool Program to Improve Adolescent Mental Health and Physical Activity: A Pilot Study
NCT06686784
Personalized Nutrition Therapy Using Continuous Glucose Monitoring to Improve Outcomes in Type 2 Diabetes Mellitus
NCT06465693
teleABLE to Reduce Post-Stroke Sedentary Behavior
NCT06312709
Minnesota Inclusive LTSS for LGBTQ Seniors
NCT05530590
Community-based Communication for Blood Donation in Ghana
NCT05973890
BLOODSAFE Ghana- Iron and Nutritional Counselling Strategy
NCT06101238
SGLT2 Inhibitor Therapy in Cystic Fibrosis-related Diabetes
NCT06149793
Vyvanse in Children Aged 6 to 12 Years
NCT05416125
Blood Biomarkers in Pediatric Kidney Transplant Recipients
NCT05477082
EPI-MINN: Targeting Cognition and Motivation - National
NCT05877716
A Pragmatic Trial of Chronic Disease Approaches to Ameliorate Tobacco Related Cardiovascular Disease Health Disparities
NCT05671380
The PorchLight Project
NCT05550727
Traveling-wave Transcranial Electric Stimulation
NCT05399381
Phentermine/Topiramate in Adolescents With Type 2 Diabetes and Obesity
NCT04881799
Contingency Management for Opioid and Stimulant Use Disorders in Primary Care
NCT05288751
TRE in Type 2 Diabetes (See Food Study 3)
NCT05290246
What is open in the University of Minnesota pipeline
180 recruiting of 966 indexed (19% open); 671 completed (69%).
Phase mix: 71 late (III/IV) vs 206 early (I/II) (early-phase heavy).
Top condition: Obesity (14 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Minnesota: open-pipeline peers nationwide
Peers matched on 966 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 966 trials (± recruiting share)
- Columbia University · 958 trials · 18% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Alabama at Birmingham · 19% recruiting · 1,160 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Minnesota page
966 registered trials is a research-attention snapshot, not an endorsement of University of Minnesota or any single study.
- 180 of University of Minnesota's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Minnesota studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Minnesota pipeline card: 966 registered trials from official public datasets.Report a data error.